Production (Stage)
Sana Biotechnology, Inc.
SANA
$2.27
$0.020.89%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 11.48M | 17.28M | 14.05M | 16.44M | 16.27M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 48.77M | 51.86M | 61.53M | 52.74M | 105.34M |
| Operating Income | -48.77M | -51.86M | -61.53M | -52.74M | -105.34M |
| Income Before Tax | -49.39M | -49.07M | -59.92M | -50.29M | -107.48M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -49.39M | -49.07M | -59.92M | -50.29M | -107.48M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -49.39M | -49.07M | -59.92M | -50.29M | -107.48M |
| EBIT | -48.77M | -51.86M | -61.53M | -52.74M | -105.34M |
| EBITDA | -45.12M | -48.06M | -57.47M | -48.85M | -101.59M |
| EPS Basic | -0.21 | -0.21 | -0.25 | -0.21 | -0.49 |
| Normalized Basic EPS | -0.13 | -0.12 | -0.16 | -0.14 | -0.29 |
| EPS Diluted | -0.21 | -0.21 | -0.25 | -0.21 | -0.49 |
| Normalized Diluted EPS | -0.13 | -0.12 | -0.16 | -0.14 | -0.29 |
| Average Basic Shares Outstanding | 237.58M | 236.30M | 235.41M | 234.44M | 217.29M |
| Average Diluted Shares Outstanding | 237.58M | 236.30M | 235.41M | 234.44M | 217.29M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |